Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
28.9M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
297K
-
Shares change
-
+65.8K
-
Total reported value, excl. options
-
$1.04M
-
Value change
-
+$236K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$3.51
Significant Holders of MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) as of Q4 2022
10 filings reported holding MAIA - MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 297K shares
of 28.9M outstanding shares and own 1.03% of the company stock.
Largest 10 shareholders include Lynwood Capital Management Inc. (250K shares), Centric Wealth Management (40.2K shares), BlackRock Inc. (3.87K shares), UBS Group AG (3.03K shares), WELLS FARGO & COMPANY/MN (14 shares), BANK OF AMERICA CORP /DE/ (2 shares), MILLENNIUM MANAGEMENT LLC (0 shares), Tower Research Capital LLC (TRC) (0 shares), JANE STREET GROUP, LLC (0 shares), and OPTIMUM INVESTMENT ADVISORS (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.